46 daysTime to First Decision

Medicines, Volume 8, Issue 10

October 2021 - 6 articles

Cover Story: Obesity represents a risk factor for a variety of diseases because of its inflammatory component, among other biological patterns. Recently, with the ongoing COVID-19 crisis, a special focus has been put on obesity as a status in which antibody production, among other immune functions, is impaired, which would impact both disease pathogenesis and vaccine efficacy. Herein, we illustrate that such patterns would be due to the increased adiposity and fat distribution pattern rather than obesity (as defined by the body mass index) itself. Within this context, we also highlight the importance of the weight-loss-independent effects of exercise.View this paper

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

Select all

Review

8 Citations

7,167 Views

13 Pages

Laparoscopy in Gynecologic and Abdominal Surgery in Regional (Spinal, Peridural) Anesthesia, the Utility of the Technique during COVID-19 Pandemic

Attila Louis Major,
Kudrat Jumaniyazov,
Shahnoza Yusupova,
Ruslan Jabbarov,
Olimjon Saidmamatov and
Ivanna Mayboroda-Major

Medicines2021, 8(10), 60;https://doi.org/10.3390/medicines8100060

19 October 2021

Background: laparoscopic surgery is mainly performed in general anesthesia. Symptomatic patients infected with COVID-19 needing surgery are however at higher risk for COVID-19 complications in general anesthesia than in regional anesthesia. Even so,...

Full Article

Opinion

1 Citations

3,758 Views

4 Pages

COVID-19 Infection and Neuropathological Features

Leonardo Freire-de-Lima,
Aline Miranda Scovino,
Leonardo Marques da Fonseca,
Camilla Cristie Barreto Menezes,
Carlos Antonio do Nascimento Santos,
Marco Edilson Freire de Lima,
Debora Decote-Ricardo,
Matheus Freire-de-Lima,
Kelli Monteiro da Costa and
Jhenifer Santos dos Reis
+ 3 authors

Medicines2021, 8(10), 59;https://doi.org/10.3390/medicines8100059

11 October 2021

The pathology associated with COVID-19 infection is progressively being revealed. Recent postmortem assessments have revealed acute airway inflammation as well as diffuse alveolar damage, which bears resemblance to severe acute respiratory syndromes...

Full Article

Review

16 Citations

22,723 Views

8 Pages

Clinical Trials, Potential Mechanisms, and Adverse Effects of Arnica as an Adjunct Medication for Pain Management

Amanda G. Smith,
Victoria N. Miles,
Deltrice T. Holmes,
Xin Chen and
Wei Lei

Medicines2021, 8(10), 58;https://doi.org/10.3390/medicines8100058

9 October 2021

Arnica has traditionally been used in treating numerous medical conditions, including inflammation and pain. This review aims to summarize the results of studies testing Arnica products for pain management under different conditions, including post-o...

Full Article

Opinion

9 Citations

5,818 Views

6 Pages

Impact of Adiposity and Fat Distribution, Rather Than Obesity, on Antibodies as an Illustration of Weight-Loss-Independent Exercise Benefits

Abdelaziz Ghanemi,
Mayumi Yoshioka and
Jonny St-Amand

Medicines2021, 8(10), 57;https://doi.org/10.3390/medicines8100057

8 October 2021

Obesity represents a risk factor for a variety of diseases because of its inflammatory component, among other biological patterns. Recently, with the ongoing COVID-19 crisis, a special focus has been put on obesity as a status in which antibody produ...

Full Article

Article

10 Citations

3,722 Views

17 Pages

Lignosulfonate Rapidly Inactivates Human Immunodeficiency and Herpes Simplex Viruses

Kunihiko Fukuchi,
Takuro Koshikawa,
Daisuke Asai,
Megumi Inomata,
Hiroshi Sakagami,
Hiromu Takemura,
Taisei Kanamoto,
Hikaru Aimi and
Yuji Kikkawa

Medicines2021, 8(10), 56;https://doi.org/10.3390/medicines8100056

3 October 2021

Background: Very few studies of the antiviral potential of lignosulfonates have been published. With the aim of oral application, among various groups of natural products, the relative antiviral potency of lignosulfonate and its ability to rapidly in...

Full Article

Opinion

6 Citations

3,826 Views

6 Pages

Autoimmune Disorders & COVID-19

Leonardo Freire-de-Lima,
Aline Miranda Scovino,
Camilla Cristie Barreto Menezes,
Leonardo Marques da Fonseca,
Jhenifer Santos dos Reis,
Marcos André Rodrigues da Costa Santos,
Kelli Monteiro da Costa,
Carlos Antonio do Nascimento Santos,
Celio Geraldo Freire-de-Lima and
Alexandre Morrot

Medicines2021, 8(10), 55;https://doi.org/10.3390/medicines8100055

28 September 2021

Coronavirus disease 2019 (COVID-19) can progress to severe pneumonia with respiratory failure and is aggravated by the deregulation of the immune system causing an excessive inflammation including the cytokine storm. Since 2019, several studies regar...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Medicines - ISSN 2305-6320

Imprint

Download Flyer